-
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
Monday, April 14, 2025 - 5:14am | 753The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) and Ginkgo Bioworks Holdings Inc. (NYSE:DNA) rallying last week. What Happened: On...
-
Cronos Launches Spinach FEELZ Day Trip Gummies With THC And CBC
Wednesday, December 7, 2022 - 12:27pm | 344Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) launched a CBC-focused product, the Spinach FEELZ THC+CBC Day Trip Mango Lime gummies, utilizing Ginkgo Bioworks’ platform for organism design and development. The Spinach FEELZ Day Trip gummies feature a 3:1 ratio of CBC to THC or 10mg of THC and...
-
Cronos Group & Ginkgo Bioworks Launch First Cultured Cannabinoid Product: A THC & CBG Infused Gummy
Wednesday, October 20, 2021 - 10:11am | 587On Wednesday, the Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced the launch of what it is calling the first cannabis edible in Canada to contain THC and cultured cannabigerol (CBG) from fermentation in a sweet gummy for adult consumers. The product, dubbed SPINACH FEELZ...
-
5 Largest US M&A Deals In Q2: Railways, Health Care, REITS And More
Monday, September 6, 2021 - 9:30am | 918Global merger and acquisition activity topped $1 trillion in the second quarter of 2021, with the U.S alone topping $500 billion. This was the third quarter in a row that this happened globally and in the U.S. The second quarter started strong with four of the five largest deals announced in the...
-
What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physical Goods Industry'
Tuesday, May 11, 2021 - 3:29pm | 656A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisition Corp (NASDAQ: SRNG) that values the company at a pre money equity value of $15 billion. Soaring...
-
Synlogics Wins $80M Investment From Ginkgo
Wednesday, June 12, 2019 - 10:36am | 179Synlogic, Inc. (NASDAQ: SYBX) announced a platform collaboration to speed up the development of Synlogic’s pipeline of Synthetic Biotic medicines using Ginkgo’s cell programming platform. The agreement provides an $80.0 million equity investment at a premium in Synlogic by Ginkgo and...
-
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Friday, September 7, 2018 - 7:13pm | 4004A four-day week shortened by Labor Day still brought substantial news in the cannabis sector. “Even though this week was a shortened trading week, there were still lots of financial deals happening. Cronos Group agreed to a partnership with Gingko Bioworks that could be worth $122...